Shoei Co., Limited (7839.T)
JPY 2212.0
(-1.86%)
JPY 2212.0
(-1.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 33.61 Billion | 28.95 Billion | 23.75 Billion | 19.47 Billion | 18.61 Billion | 17.14 Billion |
| Cost of Revenue | 18.31 Billion | 15.77 Billion | 13.65 Billion | 11.3 Billion | 11.1 Billion | 10.3 Billion |
| Gross Profit | 15.3 Billion | 13.17 Billion | 10.1 Billion | 8.16 Billion | 7.51 Billion | 6.84 Billion |
| Operating Expenses | 5.47 Billion | 4.79 Billion | 4.07 Billion | 3.42 Billion | 3.3 Billion | 3.11 Billion |
| Selling, General and Administrative Expenses | 2.38 Billion | 2.1 Billion | 1.73 Billion | 1.46 Billion | 1.43 Billion | 1.41 Billion |
| Research and Development Expenses | - | 185.35 Million | 183.99 Million | 134.32 Million | 147.01 Million | 106.13 Million |
| Other Expenses | 3.09 Billion | 2.68 Billion | 2.33 Billion | 1.96 Billion | 1.87 Billion | 10.01 Million |
| Cost and Expenses | 23.79 Billion | 20.57 Billion | 17.72 Billion | 14.73 Billion | 14.41 Billion | 13.41 Billion |
| Operating Income | 9.82 Billion | 8.38 Billion | 6.02 Billion | 4.74 Billion | 4.2 Billion | 3.73 Billion |
| Interest Expense | 8.94 Million | 7.21 Million | 6.8 Million | 6.01 Million | 77 Thousand | - |
| Income Tax Expense | 2.79 Billion | 2.48 Billion | 1.68 Billion | 1.39 Billion | 1.24 Billion | 1.16 Billion |
| Earnings before Tax | 9.85 Billion | 8.5 Billion | 6.09 Billion | 4.74 Billion | 4.18 Billion | 3.74 Billion |
| Net Income | 7.06 Billion | 6.01 Billion | 4.4 Billion | 3.34 Billion | 2.93 Billion | 2.57 Billion |
| Earnings Per Share Basic | 131.74 | 112.19 | 82.10 | 61.94 | 53.29 | 46.81 |
| Earnings Per Share Diluted | 131.74 | 112.19 | 82.10 | 61.94 | 53.29 | 46.81 |
| Weighted Average Shares Outstanding | 53.65 Million | 53.64 Million | 53.68 Million | 54.05 Million | 55.08 Million | 55.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 53.65 Million | 53.64 Million | 53.68 Million | 54.05 Million | 55.08 Million | 55.08 Million |
| Gross Margin | 0.46 | 0.46 | 0.43 | 0.42 | 0.40 | 0.40 |
| EBIT Margin | 0.34 | 0.33 | 0.30 | 0.29 | 0.27 | 0.27 |
| Profit Margin | 0.21 | 0.21 | 0.19 | 0.17 | 0.16 | 0.15 |
| EBITDA | 11.35 Billion | 9.52 Billion | 7.19 Billion | 5.66 Billion | 5.04 Billion | 4.69 Billion |
| Earnings Before Tax Margin | 0.29 | 0.29 | 0.25 | 0.24 | 0.23 | 0.22 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 9.04 Billion | 8.3 Billion | 8.14 Billion | 33.61 Billion | 9.02 Billion | 9.37 Billion |
| Cost of Revenue | 5.05 Billion | 4.56 Billion | 4.06 Billion | 18.31 Billion | 5.43 Billion | 4.93 Billion |
| Gross Profit | 3.99 Billion | 3.74 Billion | 4.08 Billion | 15.3 Billion | 3.58 Billion | 4.44 Billion |
| Operating Expenses | 1.42 Billion | 1.3 Billion | 1.24 Billion | 5.47 Billion | 1.8 Billion | 1.33 Billion |
| Selling, General and Administrative Expenses | 1.42 Billion | 1.3 Billion | 1.2 Billion | - | 1.74 Billion | 1.28 Billion |
| Research and Development Expenses | - | 42.58 Million | 40.46 Million | - | 53.92 Million | 45.71 Million |
| Other Expenses | 1 Million | 15.45 Million | -3.14 Million | 39.34 Million | 5.47 Million | 2.59 Million |
| Cost and Expenses | 6.47 Billion | 5.86 Billion | 5.3 Billion | 23.79 Billion | 7.23 Billion | 6.26 Billion |
| Operating Income | 2.56 Billion | 2.43 Billion | 2.83 Billion | 9.82 Billion | 1.78 Billion | 3.11 Billion |
| Interest Expense | 9.24 Million | 8.35 Million | 8.47 Million | 8.94 Million | 3.08 Million | 2.33 Million |
| Income Tax Expense | 827 Million | 789.92 Million | 813.82 Million | 2.79 Billion | 351.08 Million | 1 Billion |
| Earnings before Tax | 2.71 Billion | 2.61 Billion | 2.72 Billion | 9.85 Billion | 1.73 Billion | 3.23 Billion |
| Net Income | 1.88 Billion | 1.82 Billion | 1.91 Billion | 7.06 Billion | 1.37 Billion | 2.23 Billion |
| Earnings Per Share Basic | 35.89 | 34.21 | 35.88 | - | 25.73 | 41.58 |
| Earnings Per Share Diluted | 35.89 | 34.21 | 35.88 | - | 25.73 | 41.58 |
| Weighted Average Shares Outstanding | 52.52 Million | 53.33 Million | 53.33 Million | 53.65 Million | 53.61 Million | 53.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 52.52 Million | 53.33 Million | 53.33 Million | 53.65 Million | 53.61 Million | 53.68 Million |
| Gross Margin | 0.44 | 0.45 | 0.50 | 0.46 | 0.40 | 0.47 |
| EBIT Margin | 0.32 | 0.29 | 0.39 | - | 0.19 | 0.35 |
| Profit Margin | 0.21 | 0.22 | 0.23 | 0.21 | 0.15 | 0.24 |
| EBITDA | 2.93 Billion | 2.43 Billion | 3.2 Billion | - | 1.73 Billion | 3.23 Billion |
| Earnings Before Tax Margin | 0.28 | 0.29 | 0.35 | 0.29 | 0.20 | 0.33 |
7609
COIN
ONCO3
THEMISMED
BNL
6549